AUDRA BALLASH: Open Payments
NPI 1558870139 · LAKEWOOD RANCH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,323 in 105 payments from 17 companies in 2025. Trend: 2023 $1,143 · 2024 $1,920 · 2025 $2,323
Food & beverage: $2,236Education: $87
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $548 |
| Janssen Biotech, Inc. | 11 | $343 |
| Ardelyx, Inc. | 16 | $315 |
| QOL Medical, LLC | 6 | $213 |
| Aimmune Therapeutics, Inc. | 11 | $137 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $116 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $91 |
| Madrigal Pharmaceuticals | 3 | $86 |
| PFIZER INC. | 5 | $82 |
| VIVUS LLC | 3 | $66 |
Products named: TREMFYA, RINVOQ, IBSRELA, Sucraid, SKYRIZI, ZENPEP, ENTYVIO, XIFAXAN.
Industry payments across FL — which companies pay providers there.
